Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | FANCE |
| Gene Name: | FANCE |
| Protein Full Name: | Fanconi anemia group E protein |
| Alias: | FACE; FAE; Fanconi anemia, complementation group E |
| Mass (Da): | 58711 |
| Number AA: | 536 |
| UniProt ID: | Q9HB96 |
| Locus ID: | 2178 |
| COSMIC ID: | FANCE |
| Gene location on chromosome: | 6p21 |
| Cancer protein type: | TSP |
| Effect of cancer mutation on protein: | LOSS |
| Effect of active protein on cancer: | INHIBIT |
| Number of cancer specimens: | 20417 |
| Percent of cancer specimens with mutations: | 0.37 |
| Mutations observed as inherited: | NA |
| Found in amplified chromosomal regions in human cancers: | NA |
| Deregulated in translocations: | NA |
| Deregulated by viral insertion: | NA |
| Transduced into viral genome: | NA |
| Gene undergoes hypermethylation: | NA |
| Normal role description: | FANCE plays a part in the Fanconi anemia complex in DNA cross-link repair and protection against chromosome breakages. Defects have been associated with predisposition to malignancy development such as leukemia |